Back to search
FDAFDA · Food and drugs·Recall number D-0174-2017

PAPA/PHEN/PROST (papverine/phentolamine/prostaglandin) 30 mg/4 mg/0.04 mg/mL Injection, 1 mL vials, Fallon Wellness Pharmacy LLC, 1057 Troy-Schenectady Rd, Latham, NY 12110.

Published December 14, 2016 · Recall initiated: November 2, 2016

Summary

FDA records drug Class II recall D-0174-2017, published December 14, 2016 and initiated November 2, 2016. Recalling firm: Fallon Wellness Pharmacy, L.L.C.; Status: Terminated; Reported quantity: 5 vials; Lot: Lot #: 09202016@8, Exp 11/04/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: product produced on a day there was an excursion in environmental monitoring data.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fallon Wellness Pharmacy, L.L.C.
Distributor
NY
Lot
Lot #: 09202016@8, Exp 11/04/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PAPA/PHEN/PROST (papverine/phentolamine/prostaglandin) 30 mg/4 mg/0.04 mg/mL Injection, 1 mL vials, Fallon Wellness Pharmacy LLC, 1057 Troy-Schenectady Rd, Latham, NY 12110. recalled?

Yes. FDA published recall D-0174-2017 on December 14, 2016. Reported hazard: Lack of Assurance of Sterility: product produced on a day there was an excursion in environmental monitoring data.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit